Helix: Sarah Bobulsky, Craig Newman, Daniel Lee
Helix has made three new executive appointments. Sarah Bobulsky has been promoted to CFO, Craig Newman has joined as senior VP of health systems, and Daniel Lee has joined as senior VP of life sciences and growth.
Bobulksy was previously Helix's VP of commercial and has been with the company for six years.
Newman, who will oversee Helix's expansion of strategic partnerships with health systems, comes to the firm from HealthChannels, where he was chief strategy officer. Prior to that, he spent nine years at The Advisory Board Company, a health systems consultancy.
Lee, who will oversee partnerships with life sciences, payor, and government customers, was most recently senior VP of enterprise modernization at CVS Health. Previously, he spent 17 years at Pfizer, including as VP of consulting and execution.
Pacific Biosciences: Lara Toerien
Lara Toerien has been appointed as VP and general manager for the Americas at Pacific Biosciences. She comes to PacBio from Illumina, where she worked for 16 years, most recently as senior regional sales director for the Northeast. Previously, she was with Invitrogen. Toerien holds a Ph.D. in biology from the University of California, San Diego and a B.S. in molecular and cell biology from Penn State University.
SomaLogic: Adam Taich
SomaLogic has appointed Adam Taich its chief business officer. He will also serve on the company's executive committee. Taich was most recently VP and general manager of the molecular biology business of Thermo Fisher Scientific. Earlier, he led the protein and cell analysis business and led strategy and corporate development for the life sciences group at the company.
For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.